BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Méndez-Sánchez N, Zamarripa-Dorsey F, Panduro A, Purón-González E, Coronado-Alejandro EU, Cortez-Hernández CA, Higuera de la Tijera F, Pérez-Hernández JL, Cerda-Reyes E, Rodríguez-Hernández H, Cruz-Ramón VC, Ramírez-Pérez OL, Aguilar-Olivos NE, Rodríguez-Martínez OF, Cabrera-Palma S, Cabrera-Álvarez G. Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions. World J Clin Cases 2018; 6(15): 922-930 [PMID: 30568947 DOI: 10.12998/wjcc.v6.i15.922]
URL: https://www.wjgnet.com/1007-9327/full/v6/i15/922.htm
Number Citing Articles
1
Vania Cesar Cruz-Ramón, Nahum Méndez-Sánchez. The Importance of Amerindian Ancestry on Nonalcoholic Fatty Liver Disease in the Hispanic/Latino American PopulationClinical Gastroenterology and Hepatology 2019; 17(12): 2623 doi: 10.1016/j.cgh.2019.05.021
2
Jose C. Cessa-Zanatta, Carlos A. Cortez-Hernández, Daniela Goyes, Alan Bonder. Epidemiology and health care burden of autoimmune liver diseases in MexicoClinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000089
3
Yvonne Ayerki Nartey, Yaw Asante Awuku, Adwoa Agyei-Nkansah, Amoako Duah, Sally Afua Bampoh, Joshua Ayawin, Shadrack Osei Asibey, Niklas K. Björkström, Weimin Ye, Mary Yeboah Afihene, Lewis Rowland Roberts, Amelie Plymoth. Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio indexBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01581-9
4
Jorge Aquino-Matus, Misael Uribe, Norberto Chavez-Tapia. COVID-19: Current Status in Gastrointestinal, Hepatic, and Pancreatic Diseases—A Concise ReviewTropical Medicine and Infectious Disease 2022; 7(8): 187 doi: 10.3390/tropicalmed7080187
5
Carlos Moctezuma-Velazquez, Graciela Castro-Narro, Pablo Simó, Elisabet Viayna, Susana Aceituno, Maria Soler, Aldo Torre. Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspectiveAnnals of Hepatology 2022; 27(2): 100673 doi: 10.1016/j.aohep.2022.100673
6
M. Martinez-Castillo, I. Altamirano-Mendoza, S. Sánchez-Valle, L. García-Islas, M. Sánchez-Barragán, M. Hernández-Santillán, A. Hernández-Barragán, J.L. Pérez-Hernández, F. Higuera-de la Tijera, G. Gutierrez-Reyes. Desregulación inmunológica y fisiopatología del consumo de alcohol y la enfermedad hepática alcohólicaRevista de Gastroenterología de México 2023; 88(2): 136 doi: 10.1016/j.rgmx.2023.01.002
7
Laura Esthela Cisneros Garza, Ignacio Aiza Haddad. Hepatocellular Carcinoma in MexicoClinical Liver Disease 2022; 19(2): 73 doi: 10.1002/cld.1196
8
L.E. Cisneros-Garza, M.S. González-Huezo, C. Moctezuma-Velázquez, L. Ladrón de Guevara-Cetina, M. Vilatobá, I. García-Juárez, R. Alvarado-Reyes, G.A. Álvarez-Treviño, S. Allende-Pérez, L. Bornstein-Quevedo, G. Calderillo-Ruiz, M.A. Carrillo-Martínez, M. Castillo-Barradas, E. Cerda-Reyes, J.A. Félix-Leyva, J.A. Gabutti-Thomas, J. Guerrero-Ixtlahuac, F. Higuera-de-la-Tijera, D. Huitzil-Meléndez, E. Kimura-Hayama, P.A. López-Hernández, R. Malé-Velázquez, N. Méndez-Sánchez, M.A. Morales-Ruiz, E. Ruíz-García, J.F. Sánchez-Ávila, L. Torrecillas-Torres. II Consenso Mexicano de Carcinoma Hepatocelular. Parte I: Epidemiología y diagnósticoRevista de Gastroenterología de México 2022; 87(2): 216 doi: 10.1016/j.rgmx.2021.10.002
9
Jacqueline Córdova-Gallardo, Andrew P. Keaveny, Xingshun Qi, Nahum Méndez-Sánchez. Metabolic associated fatty liver disease and acute-on-chronic liver failure: common themes for common problemsEuropean Journal of Gastroenterology & Hepatology 2021; 33(1S): e84 doi: 10.1097/MEG.0000000000002335
10
Edgar D. Copado-Villagrana, Antonio Pizuorno, Adrián García-Suárez, Julio C. Abarca, Gisela DuPont, Socorro Jaramillo-Bueno, Nora A. Fierro. IL-18 discriminates highly frequent hepatitis E virus positive from negative blood donors in MexicoAnnals of Hepatology 2023; 28(5): 101117 doi: 10.1016/j.aohep.2023.101117
11
C.E. Coronel-Castillo, J. Contreras-Carmona, A.C. Frati-Munari, M. Uribe, N. Méndez-Sánchez. Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathyRevista de Gastroenterología de México (English Edition) 2020; 85(1): 56 doi: 10.1016/j.rgmxen.2019.09.003
12
Alex Gonzalez-Chagolla, Antonio Olivas-Martinez, Jesus Ruiz-Manriquez, Maximiliano Servín-Rojas, Eric Kauffman-Ortega, Luis Carlos Chávez-García, Oscar Juárez-León, Jacqueline Cordova-Gallardo, Juan Daniel Díaz-García, Maria Sarai Gonzalez-Huezo, Guadalupe Milanés-Lizarraga, Victor M Paez-Zayas, Mauricio Castillo-Barradas, Orestes de Jesús Cobos-Quevedo, Francisco Isaí García-Juárez, José Alberto Romero-Lozanía, Liz Toapanta-Yanchapaxi, Juan Francisco Sánchez-Avila, José Alonso Avila-Rojo, Aliberth Bonilla-Salas, Michelle Dirthurbide-Hernández, Isaac Ruiz, Ana K. Valenzuela-Vidales, Ignacio García-Juárez. Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central MexicoThe Lancet Regional Health - Americas 2022; 7: 100151 doi: 10.1016/j.lana.2021.100151
13
Kristin E. Morrill, Rebecca M. Crocker, Melanie D. Hingle, Cynthia A. Thomson, David O. Garcia. Awareness, Knowledge, and Misperceptions Related to Nonalcoholic Fatty Liver Disease in a Community Sample of Mexican-Origin Women: A Mixed Methods StudyFrontiers in Public Health 2021; 9 doi: 10.3389/fpubh.2021.626428
14
Mezgebu Legesse Habte, Etsegenet Assefa Beyene, Teka Obsa Feyisa. Management of Dyslipidemia2021;  doi: 10.5772/intechopen.95756
15
K.P. Rojas-Pintor, M.A. Arizmendi-Villarreal, J.E. Aparicio-Salas, D.P. Moreno-Peña, D. Hernández-Barajas, P. Cordero-Pérez, L.E. Muñoz-Espinosa. Differences in the presentation and treatment of primary liver tumors at a hepatology center and an oncology centerRevista de Gastroenterología de México (English Edition) 2021; 86(4): 370 doi: 10.1016/j.rgmxen.2021.07.006
16
Ellen Mooneyhan, Alethse De la Torre Rosas, Daniel Bernal Serrano, Ivane Gamkrelidze, Maria Jesus Sanchez, David Kershenobich, Leandro Sereno, Homie Razavi. Cost‐effectiveness and economic investment to eliminate chronic hepatitis C in MexicoJournal of Viral Hepatitis 2023; 30(6): 551 doi: 10.1111/jvh.13828
17
M. Martinez-Castillo, I. Altamirano-Mendoza, S. Sánchez-Valle, L. García-Islas, M. Sánchez-Barragán, M. Hernández-Santillán, A. Hernández-Barragán, J.L. Pérez-Hernández, F. Higuera-de la Tijera, G. Gutierrez-Reyes. Immune dysregulation and pathophysiology of alcohol consumption and alcoholic liver diseaseRevista de Gastroenterología de México (English Edition) 2023; 88(2): 136 doi: 10.1016/j.rgmxen.2023.03.003
18
Virginia Sedeño-Monge, Saul Laguna-Meraz, Gerardo Santos-López, Arturo Panduro, Francisca Sosa-Jurado, Alexis Jose-Abrego, Daniel Meléndez-Mena, Marco A. Muñoz-Ramírez, Monserrat Cosme-Chávez, Sonia Roman. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)Annals of Hepatology 2021; 20: 100292 doi: 10.1016/j.aohep.2020.100292
19
L.E. Cisneros-Garza, M.S. González-Huezo, C. Moctezuma-Velázquez, L. Ladrón de Guevara-Cetina, M. Vilatobá, I. García-Juárez, R. Alvarado-Reyes, G.A. Álvarez-Treviño, S. Allende-Pérez, L. Bornstein-Quevedo, G. Calderillo-Ruiz, M.A. Carrillo-Martínez, M. Castillo-Barradas, E. Cerda-Reyes, J.A. Félix-Leyva, J.A. Gabutti-Thomas, J. Guerrero-Ixtlahuac, F. Higuera-de-la-Tijera, D. Huitzil-Meléndez, E. Kimura-Hayama, P.A. López-Hernández, R. Malé-Velázquez, N. Méndez-Sánchez, M.A. Morales-Ruiz, E. Ruíz-García, J.F. Sánchez-Ávila, L. Torrecillas-Torres. The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosisRevista de Gastroenterología de México (English Edition) 2022; 87(2): 216 doi: 10.1016/j.rgmxen.2021.10.009
20
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic DiseasesJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00131
21
Shreya C. Pal, Mohammed Eslam, Nahum Mendez-Sanchez. Detangling the interrelations between MAFLD, insulin resistance, and key hormonesHormones 2022; 21(4): 573 doi: 10.1007/s42000-022-00391-w
22
Huimin Chen, Jingjing Liu, Shufen Peng, Guang Yang, Xueer Cheng, Li Chen, Han Zhang, Ying Zhao, Ping Yao, Yuhan Tang. Autophagy and exosomes coordinately mediate quercetin's protective effects on alcoholic liver diseaseThe Journal of Nutritional Biochemistry 2023; 116: 109332 doi: 10.1016/j.jnutbio.2023.109332
23
K.P. Rojas-Pintor, M.A. Arizmendi-Villarreal, J.E. Aparicio-Salas, D.P. Moreno-Peña, D. Hernández-Barajas, P. Cordero-Pérez, L.E. Muñoz-Espinosa. Diferencias de la presentación y tratamiento en las neoplasias primarias de hígado en un centro de hepatología y un centro oncológicoRevista de Gastroenterología de México 2021; 86(4): 370 doi: 10.1016/j.rgmx.2020.08.005
24
C.E. Coronel-Castillo, J. Contreras-Carmona, A.C. Frati-Munari, M. Uribe, N. Méndez-Sánchez. Eficacia de la rifaximina en los diferentes escenarios clínicos de la encefalopatía hepáticaRevista de Gastroenterología de México 2020; 85(1): 56 doi: 10.1016/j.rgmx.2019.09.001
25
Juan Manuel Aldana Ledesma, Daniela Vázquez Rodríguez, Monserrat Lazcano Becerra, Edgar Santino García Jiménez, Diana Karen Tapia Calderón, Miguel Ángel Ibarra Estrada, Francisco Alejandro Félix Téllez, José Antonio Velarde Ruiz Velasco. Comparison of different tools for the evaluation of malnutrition and sarcopenia in patients with liver cirrhosisNutrición Hospitalaria 2023;  doi: 10.20960/nh.03837
26
Daniel Melendez-Mena, Miguel Angel Mendoza-Torres, Virginia Sedeño-Monge, Víctor Hugo García y García, Elain Rivera-García, Laura Sánchez-Reza, María del Carmen Baxin Domínguez, Belinda Guzmán-Flores, Ygnacio Martinez-Laguna, José Manuel Coronel Espinoza, Iván Galindo-Santiago, Juan Carlos Flores-Alonso, Verónica Vallejo-Ruiz, Paulina Cortes-Hernandez, Julio Reyes-Leyva, Francisca Sosa-Jurado, Gerardo Santos-López. Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapyPeerJ 2021; 9: e12051 doi: 10.7717/peerj.12051